Arrowhead Research | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Arrowhead Research USD 185.71M 133.92M 2025-03
Incyte USD 2.42B 13.08M 2025-06
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Ligand Pharmaceuticals USD 256.89M 184.58M 2025-03
Merck USD 8.63B 4.61B 2025-03
Moderna USD 1.62B 304M 2025-03
Novartis USD 6.66B 410M 2025-06
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
TG Therapeutics USD 179.89M 15.93M 2024-12
Ultragenyx Pharmaceutical USD 563M 389.27M 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Xencor USD 39.67M 1.2M 2025-03


Arrowhead Research Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.